Moran Wealth Management’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-135,938
Closed -$2.77M 384
2023
Q1
$2.77M Sell
135,938
-40,667
-23% -$818K 0.1% 196
2022
Q4
$3.75M Buy
+176,605
New +$3.66M 0.14% 177

Other funds holding BTAL

Moran Wealth Management's BTAL Position: Q2 2023 in Review

Moran Wealth Management sold out of AGF US Market Neutral Anti-Beta Fund (BTAL) in Q2 2023, closing a stake of 135,938 shares — an estimated $2.77M sold.

Moran Wealth Management first reported a position in BTAL in Q4 2022 and held it in 2 quarters. The position peaked at $3.75M in Q4 2022. 72 funds tracked by Wall St. Rank hold BTAL as of Q2 2023.

  • Moran Wealth Management reported no remaining AGF US Market Neutral Anti-Beta Fund position as of Q2 2023 after selling out during the quarter.
  • Moran Wealth Management sold 135,938 AGF US Market Neutral Anti-Beta Fund shares in Q2 2023, an estimated $2.77M.
  • Moran Wealth Management first reported a position in AGF US Market Neutral Anti-Beta Fund in Q4 2022 and held it in 2 quarters.
  • Moran Wealth Management's AGF US Market Neutral Anti-Beta Fund position peaked at $3.75M in Q4 2022.
  • 72 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q2 2023.

Based on Moran Wealth Management's 13F filing for Q2 2023, filed 10 Aug 2023.